Wolverine Trading, LLC Merck & Co., Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $5.3 Million - $6.15 Million	47,700 Added 13.97%	389,200 $44.2 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $46.6 Million - $50 Million	-376,100 Reduced 52.41%	341,500 $42.3 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $30.9 Million - $36.1 Million	273,300 Added 61.51%	717,600 $94.7 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $4.25 Million - $4.62 Million	-42,400 Reduced 8.71%	444,300 $48.4 Million
Q3 2023 Nov 15, 2023	SELL	$102.95 - $114.33 $4.41 Million - $4.89 Million	-42,800 Reduced 8.08%	486,700 $50.1 Million
Q2 2023 Aug 23, 2023	BUY	$108.61 - $118.38 $57.5 Million - $62.7 Million	529,500 New	529,500 $61.1 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $4.78 Million - $5.37 Million	-56,500 Reduced 9.0%	571,100 $49.5 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $17.8 Million - $20.1 Million	212,700 Added 51.27%	627,600 $58.1 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $40.7 Million - $45.7 Million	-554,300 Reduced 57.19%	414,900 $34.2 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $30.5 Million - $38.2 Million	421,900 Added 77.09%	969,200 $74.8 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $23.6 Million - $26 Million	329,300 Added 151.06%	547,300 $41.1 Million
Q2 2021 Aug 06, 2021	SELL	$70.31 - $77.77 $11.2 Million - $12.4 Million	-160,000 Reduced 42.33%	218,000 $16.8 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $11.1 Million - $13.1 Million	160,900 Added 74.11%	378,000 $29.1 Million
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $11.5 Million - $12.7 Million	-159,800 Reduced 42.4%	217,100 $17.5 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $8.67 Million - $9.83 Million	118,500 Added 45.86%	376,900 $30.9 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $3.4 Million - $3.87 Million	-48,300 Reduced 15.75%	258,400 $19.7 Million
Q1 2020 May 11, 2020	SELL	$63.36 - $87.82 $2.67 Million - $3.7 Million	-42,100 Reduced 12.07%	306,700 $23.6 Million
Q4 2019 Feb 12, 2020	SELL	$77.58 - $87.54 $1.92 Million - $2.16 Million	-24,700 Reduced 6.61%	348,800 $31.8 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $4.27 Million - $4.65 Million	56,100 Added 17.67%	373,500 $31 Million
Q2 2019 Aug 20, 2019	SELL	$69.84 - $81.59 $10.5 Million - $12.3 Million	-150,300 Reduced 32.14%	317,400 $26.6 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $570,556 - $650,752	-8,200 Reduced 1.72%	467,700 $38.9 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $31 Million - $36 Million	475,900 New	475,900 $35.9 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $15 Million - $17.6 Million	-259,200 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $433,160 - $503,455	8,500 Added 3.39%	259,200 $14.1 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $2.96 Million - $3.53 Million	57,300 Added 29.63%	250,700 $14.1 Million
Q3 2017 Nov 15, 2017	BUY	$58.67 - $63.13 $11.3 Million - $12.2 Million	193,400	193,400 $12.4 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$25.1 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$20.9 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$12 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.63 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$5.95 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $255B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account